Healthcare provider profile · identity verified

Deborah Williams, MD

Internal Medicine · MADISON, WI · NPI 1578582243

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	444	127
Levothyroxine Sodium	Levothyroxine Sodium	438	102
Amlodipine Besylate	Amlodipine Besylate	287	83
Omeprazole	Omeprazole	276	73
Lisinopril	Lisinopril	249	68
Gabapentin	Gabapentin	217	38
Rosuvastatin Calcium	Rosuvastatin Calcium	200	56
Eliquis	Apixaban	176	30
Famotidine	Famotidine	172	37
Lorazepam	Lorazepam	146	36
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	141	29
Losartan Potassium	Losartan Potassium	138	41
Simvastatin	Simvastatin	130	34
Fluticasone Propionate	Fluticasone Propionate	122	45
Metformin Hcl Er	Metformin Hcl	114	31
Hydrochlorothiazide	Hydrochlorothiazide	113	31
Metoprolol Succinate	Metoprolol Succinate	109	31
Ozempic	Semaglutide	101	16
Clonazepam	Clonazepam	100	16
Zolpidem Tartrate	Zolpidem Tartrate	99	21
Duloxetine Hcl	Duloxetine Hcl	98	17
Fluoxetine Hcl	Fluoxetine Hcl	94	20
Oxycodone Hcl	Oxycodone Hcl	94	19
Atenolol	Atenolol	93	23
Trazodone Hcl	Trazodone Hcl	86	25
Jardiance	Empagliflozin	81	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	80	20
Escitalopram Oxalate	Escitalopram Oxalate	80	21
Sertraline Hcl	Sertraline Hcl	79	18
Carvedilol	Carvedilol	77	16
Acyclovir	Acyclovir	75	21
Albuterol Sulfate Hfa	Albuterol Sulfate	67	23
Metformin Hcl	Metformin Hcl	64	17
Alendronate Sodium	Alendronate Sodium	62	19
Furosemide	Furosemide	62	16
Irbesartan	Irbesartan	59	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	58	suppressed
Alprazolam	Alprazolam	56	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	56	15
Bupropion Xl	Bupropion Hcl	55	16
Spironolactone	Spironolactone	55	14
Warfarin Sodium	Warfarin Sodium	53	11
Diazepam	Diazepam	52	suppressed
Xarelto	Rivaroxaban	52	suppressed
Mirtazapine	Mirtazapine	51	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	51	suppressed
Glipizide	Glipizide	46	11
Pantoprazole Sodium	Pantoprazole Sodium	46	15
Estradiol	Estradiol	45	21
Citalopram Hbr	Citalopram Hydrobromide	44	12
Prednisone	Prednisone	42	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	41	11
Ezetimibe	Ezetimibe	40	suppressed
Tresiba Flextouch U-100	Insulin Degludec	40	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	38	13
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	38	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Tramadol Hcl	Tramadol Hcl	36	suppressed
Arnuity Ellipta	Fluticasone Furoate	35	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	33	suppressed
Diclofenac Sodium	Diclofenac Sodium	30	suppressed
Ondansetron Hcl	Ondansetron Hcl	30	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Amoxicillin	Amoxicillin	29	23
Ketoconazole	Ketoconazole	29	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	29	29
Potassium Chloride	Potassium Chloride	28	suppressed
Valacyclovir	Valacyclovir Hcl	28	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	27	suppressed
Montelukast Sodium	Montelukast Sodium	27	suppressed
Trulicity	Dulaglutide	27	suppressed
Tresiba Flextouch U-200	Insulin Degludec	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	19
Allopurinol	Allopurinol	25	suppressed
Aripiprazole	Aripiprazole	25	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Fluconazole	Fluconazole	25	suppressed
Mounjaro	Tirzepatide	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Lovastatin	Lovastatin	24	suppressed
Morphine Sulfate Er	Morphine Sulfate	24	suppressed
Nifedipine Er	Nifedipine	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	24	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Novolog Flexpen	Insulin Aspart	22	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Oxycontin	Oxycodone Hcl	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	12
Acetaminophen-Codeine	Acetaminophen With Codeine	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Celecoxib	Celecoxib	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	19	suppressed
Estring	Estradiol	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	18	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Meloxicam	Meloxicam	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Topiramate	Topiramate	17	suppressed
Effexor Xr	Venlafaxine Hcl	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Clopidogrel	Clopidogrel Bisulfate	14	suppressed
Dilt-Xr	Diltiazem Hcl	14	suppressed
Epinephrine	Epinephrine	14	suppressed
Fenofibrate	Fenofibrate,micronized	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Nystatin	Nystatin	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Testosterone	Testosterone	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Buprenorphine	Buprenorphine	12	suppressed
Dextroamphetamine Sulfate	Dextroamphetamine Sulfate	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Naproxen	Naproxen	12	suppressed
Temazepam	Temazepam	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error